SlideShare a Scribd company logo
COAGULATION
BY ADU BASI
1
INTRODUCTION
•Coagulation or clotting means to stop the flow of blood by forming a clot or a process of
changing from a liquid to a gel.
•It involves; the blood vessels, blood coagulation factors, inhibitors, platelets, fibrinolytic system
as well as co-factors to achieve haemostasis.
•Coagulation studies are a group of haematologic studies that reflect the function of blood vessels,
platelets, and coagulation factors, which all work in harmony to achieve haemostasis.
•Clinician must have access to a variety of relevant tests in order to achieve a specific or correct
diagnosis.
•A blood clot is formed by a network of fibrin threads. In this network, there are trapped red blood
cells, platelets and white blood cells.
2
DEMONSTRATION OF COAGULATION
IN VIVO (INTRO. CONT’D)
3
Factor X- Stuart-Prower
Factor IX- Christmas
Factor XI- Plasma
Thromboplastin Antecedent
Factor XII- Hageman
CLINICAL SIGNIFICANCE
•It is to achieve haemostasis; (Thrombosis and haemorrhage)
•Clotting disorders can cause a dangerous amount of bleeding or clotting. Coagulation tests
measure various proteins and how they function.
•Liver disease, Thrombophilia, Haemophilia interfere with an individual’s ability to clot.
•Coagulation tests are useful in monitoring people who take medications that affect clotting ability.
Conditions that can cause coagulation problems include:
4
PRINCIPLE OF TEST
•To evaluate the overall efficiency of the extrinsic pathway (Prothrombin) and intrinsic pathway
(Activated prothrombin time test)
•When blood vessel walls are damaged, the blood vessels contract to slow down the blood stream.
The damaged cells from the vessel’s inner wall (endothelium) trigger several processes, including
the activation of platelets and the clotting mechanism. Activated platelets stick together
(adhesion) and form complexes (aggregation) that result in the first haemostatic plug in the vessel
wall to stop the bleeding. Activated platelets also form the surface for the clotting process.
•Clotting (coagulation) occurs through the formation of a network of fibrin, involving the 'clotting
factors' being activated. The fibrin network and the haemostatic plug form a secure solution for
stopping bleeding and give the body the opportunity to repair the blood vessel.
5
PRINCIPLE OF CS-1600
•The CS-1600 is equipped with an optical fibre that supplies light at 4 different wavelengths, and a
detector capable of receiving light in multiple wavelengths.
•Multi-wavelength detector for transmitted light at 405, 575, 660 and 800 nm by splitting the light
from a halogen lamp into beams
•It allows measurement of multiple parameters with varying methodologies simultaneously.
•Measurement principles (clotting, chromogenic, immunoturbidimetric) are combined in one
analyzer.
•8 channels for clotting, chromogenic and immunoassays
6
PREPARATION BEFORE THE TEST
•Ensuring the info on sample corresponds with patient information
•The blood obtained should be only from the veins and must be clean and atraumatic.
•The sample must be in a sodium citrate anticoagulant tube and should be introduced without
frothing.
•Preparation of platelet poor plasma (4 degrees Celcius, span at 4000rpm for 13 mins.)
•For transportation of sample, sample should be transported with crushed ice and stored at -40
degrees Celsius and thawed when needed.
7
REQUIRED SAMPLE AND SAMPLE
TUBE
Required sample is plasma and should be
obtained by centrifuging blood collected by
venipuncture into a blue-top tube containing 3.2%
buffered sodium citrate. (9:1)
8
MATERIALS NEEDED
•Water bath
•Timer
•Marker or pencil
•Sodium citrate tubes
•Calcium chloride
•Tissue thromboplastin
•Micropipette and pipette tips
•Centrifuge
•AUTOMATED ANALYSER (SYSMEX CS-1600)
9
METHODOLOGY (Prothrombin)
•Set water bath at 37 degree Celsius and place a glass tube in it
•Add calcium chloride (CaCl₂) another test tube and allow to warm
•Pipette 0.1ml of patient sample into test tube and add 0.1ml of tissue thromboplastin
•Allow the mixture to warm for 3minutes.
•Wick 0.1ml of pre-warmed CaCl₂ and add to patient sample.
•As soon as a clot is seen, the timer is stopped. This time indicates the prothrombin time.
•Duplicate the test for inconveniences
•Calculate the average time in seconds for patient and control
10
RESULTS AND ITS
INTERPRETATION
•11 to 16 seconds for prothrombin time test
•30 to 40 seconds for activated prothrombin time test
•INR (International Normalized ratio):The INR is a calculation that adjusts for changes in the PT
reagents and allows for results from different laboratories to be compared.
•ISI (International Standardized index): The International Normalized Ratio (INR)/International
Sensitivity Index (ISI) system was developed as a way to standardize the prothrombin time during
the monitoring of patients undergoing oral anti-coagulant therapy with vitamin K antagonists
11
SOURCES OF ERRORS
•Undetailed medical history e.g. Aplastic anaemia, thrombocytopenia
•Drugs that act as inhibitors to coagulation/oral anticoagulants
•Diseases; obstructive liver disease and vitamin K deficiency.
12
REFERENCES
•Haemostasis - Sysmex Europe. Available at: https://www.sysmex-
europe.com/products/diagnostics/haemostasis.html (Accessed: November 28, 2022).
•Pietrangelo, A. (2018) Coagulation tests: Types, procedure, and results, Healthline. Healthline
Media. Available at: https://www.healthline.com/health/coagulation-tests (Accessed: November
28, 2022).
•Sysmex. Available at: https://www.sysmex-ap.com/wp-content/uploads/2020/08/Sysmex_CS-
1600Bro2019_FinalLR.pdf (Accessed: November 28, 2022).
13
THANK YOU
14

More Related Content

Similar to COAGULATION NAPO.pptx

1a hematology slides
1a hematology slides1a hematology slides
1a hematology slides
Samantha Watson
 
PLATELETPHRESIS .pptx
PLATELETPHRESIS .pptxPLATELETPHRESIS .pptx
PLATELETPHRESIS .pptx
Vijaysri Saravanan
 
Biomedical Instrumentation
Biomedical InstrumentationBiomedical Instrumentation
Biomedical Instrumentation
linsstalex
 
Laboratory Investigation in microbiology FINAL 123.pptx
Laboratory Investigation in microbiology FINAL 123.pptxLaboratory Investigation in microbiology FINAL 123.pptx
Laboratory Investigation in microbiology FINAL 123.pptx
GurunathVhanmane1
 
Bleeding vs coagulation disorders
Bleeding vs coagulation disordersBleeding vs coagulation disorders
Bleeding vs coagulation disorders
Ravi Kumar Meena
 
thromboelastography-140913060041-phpapp02.pdf
thromboelastography-140913060041-phpapp02.pdfthromboelastography-140913060041-phpapp02.pdf
thromboelastography-140913060041-phpapp02.pdf
Mani Reddy
 
Coagulation profile
Coagulation profileCoagulation profile
Coagulation profile
Physiology Dept
 
Laboratory_Investigation_(guru n navya).pptx
Laboratory_Investigation_(guru n navya).pptxLaboratory_Investigation_(guru n navya).pptx
Laboratory_Investigation_(guru n navya).pptx
GurunathVhanmane1
 
Coagulation profile final by Pandian M
Coagulation profile final by Pandian M Coagulation profile final by Pandian M
Coagulation profile final by Pandian M
Pandian M
 
blood practical CBC
blood practical CBCblood practical CBC
blood practical CBC
Ali Faris
 
Cardiopulmonary bypass razi shahid
Cardiopulmonary bypass razi shahidCardiopulmonary bypass razi shahid
Cardiopulmonary bypass razi shahid
razishahid
 
Bst unit-iii
Bst unit-iiiBst unit-iii
Bst unit-iii
Manjubala Us
 
Recent advances in blood banking
Recent advances in blood bankingRecent advances in blood banking
Recent advances in blood banking
Appy Akshay Agarwal
 
Clinical immunology lab and phlebotomy
Clinical immunology lab and phlebotomyClinical immunology lab and phlebotomy
Clinical immunology lab and phlebotomy
safoora pordel
 
1 general-approach-in-investigation-of-hemostasis1
1 general-approach-in-investigation-of-hemostasis11 general-approach-in-investigation-of-hemostasis1
1 general-approach-in-investigation-of-hemostasis1
DuyenNguyen307
 
Approach to bleeding disorders part II
Approach to bleeding disorders part IIApproach to bleeding disorders part II
Approach to bleeding disorders part II
drbcnayak
 
Automation in hematology
Automation in hematologyAutomation in hematology
Automation in hematology
Dr Siddartha
 
Packed cell volume physiology
Packed cell volume physiologyPacked cell volume physiology
Packed cell volume physiology
Sahil3000
 
thrombosis
thrombosisthrombosis
thrombosis
DrSekibaK
 
IT DEFENSE.pptx
IT DEFENSE.pptxIT DEFENSE.pptx
IT DEFENSE.pptx
OsinachiWilson
 

Similar to COAGULATION NAPO.pptx (20)

1a hematology slides
1a hematology slides1a hematology slides
1a hematology slides
 
PLATELETPHRESIS .pptx
PLATELETPHRESIS .pptxPLATELETPHRESIS .pptx
PLATELETPHRESIS .pptx
 
Biomedical Instrumentation
Biomedical InstrumentationBiomedical Instrumentation
Biomedical Instrumentation
 
Laboratory Investigation in microbiology FINAL 123.pptx
Laboratory Investigation in microbiology FINAL 123.pptxLaboratory Investigation in microbiology FINAL 123.pptx
Laboratory Investigation in microbiology FINAL 123.pptx
 
Bleeding vs coagulation disorders
Bleeding vs coagulation disordersBleeding vs coagulation disorders
Bleeding vs coagulation disorders
 
thromboelastography-140913060041-phpapp02.pdf
thromboelastography-140913060041-phpapp02.pdfthromboelastography-140913060041-phpapp02.pdf
thromboelastography-140913060041-phpapp02.pdf
 
Coagulation profile
Coagulation profileCoagulation profile
Coagulation profile
 
Laboratory_Investigation_(guru n navya).pptx
Laboratory_Investigation_(guru n navya).pptxLaboratory_Investigation_(guru n navya).pptx
Laboratory_Investigation_(guru n navya).pptx
 
Coagulation profile final by Pandian M
Coagulation profile final by Pandian M Coagulation profile final by Pandian M
Coagulation profile final by Pandian M
 
blood practical CBC
blood practical CBCblood practical CBC
blood practical CBC
 
Cardiopulmonary bypass razi shahid
Cardiopulmonary bypass razi shahidCardiopulmonary bypass razi shahid
Cardiopulmonary bypass razi shahid
 
Bst unit-iii
Bst unit-iiiBst unit-iii
Bst unit-iii
 
Recent advances in blood banking
Recent advances in blood bankingRecent advances in blood banking
Recent advances in blood banking
 
Clinical immunology lab and phlebotomy
Clinical immunology lab and phlebotomyClinical immunology lab and phlebotomy
Clinical immunology lab and phlebotomy
 
1 general-approach-in-investigation-of-hemostasis1
1 general-approach-in-investigation-of-hemostasis11 general-approach-in-investigation-of-hemostasis1
1 general-approach-in-investigation-of-hemostasis1
 
Approach to bleeding disorders part II
Approach to bleeding disorders part IIApproach to bleeding disorders part II
Approach to bleeding disorders part II
 
Automation in hematology
Automation in hematologyAutomation in hematology
Automation in hematology
 
Packed cell volume physiology
Packed cell volume physiologyPacked cell volume physiology
Packed cell volume physiology
 
thrombosis
thrombosisthrombosis
thrombosis
 
IT DEFENSE.pptx
IT DEFENSE.pptxIT DEFENSE.pptx
IT DEFENSE.pptx
 

More from jnrkwesi

Prevalence of anaemia among children under five
Prevalence of anaemia among children under fivePrevalence of anaemia among children under five
Prevalence of anaemia among children under five
jnrkwesi
 
Perez.pptx
Perez.pptxPerez.pptx
Perez.pptx
jnrkwesi
 
henry.pptx
henry.pptxhenry.pptx
henry.pptx
jnrkwesi
 
2. Preparation and staining of thick and thin blood films.ppt
2. Preparation and staining of thick and thin blood films.ppt2. Preparation and staining of thick and thin blood films.ppt
2. Preparation and staining of thick and thin blood films.ppt
jnrkwesi
 
KEN.pptx
KEN.pptxKEN.pptx
KEN.pptx
jnrkwesi
 
LINKS BETWEEN NUTRION AND HIV.pptx
LINKS BETWEEN NUTRION AND HIV.pptxLINKS BETWEEN NUTRION AND HIV.pptx
LINKS BETWEEN NUTRION AND HIV.pptx
jnrkwesi
 
4_5785326174687201706.pptx
4_5785326174687201706.pptx4_5785326174687201706.pptx
4_5785326174687201706.pptx
jnrkwesi
 
ADRENAL GLAND.pptx
ADRENAL GLAND.pptxADRENAL GLAND.pptx
ADRENAL GLAND.pptx
jnrkwesi
 
PfC.pptx
PfC.pptxPfC.pptx
PfC.pptx
jnrkwesi
 
bloodsmear-141130214419-conversion-gate02.pdf
bloodsmear-141130214419-conversion-gate02.pdfbloodsmear-141130214419-conversion-gate02.pdf
bloodsmear-141130214419-conversion-gate02.pdf
jnrkwesi
 
bloodfilmformalaria-150420154949-conversion-gate01.pdf
bloodfilmformalaria-150420154949-conversion-gate01.pdfbloodfilmformalaria-150420154949-conversion-gate01.pdf
bloodfilmformalaria-150420154949-conversion-gate01.pdf
jnrkwesi
 
BLOOD FILM COMMENT part one.pptx
BLOOD FILM COMMENT part one.pptxBLOOD FILM COMMENT part one.pptx
BLOOD FILM COMMENT part one.pptx
jnrkwesi
 

More from jnrkwesi (12)

Prevalence of anaemia among children under five
Prevalence of anaemia among children under fivePrevalence of anaemia among children under five
Prevalence of anaemia among children under five
 
Perez.pptx
Perez.pptxPerez.pptx
Perez.pptx
 
henry.pptx
henry.pptxhenry.pptx
henry.pptx
 
2. Preparation and staining of thick and thin blood films.ppt
2. Preparation and staining of thick and thin blood films.ppt2. Preparation and staining of thick and thin blood films.ppt
2. Preparation and staining of thick and thin blood films.ppt
 
KEN.pptx
KEN.pptxKEN.pptx
KEN.pptx
 
LINKS BETWEEN NUTRION AND HIV.pptx
LINKS BETWEEN NUTRION AND HIV.pptxLINKS BETWEEN NUTRION AND HIV.pptx
LINKS BETWEEN NUTRION AND HIV.pptx
 
4_5785326174687201706.pptx
4_5785326174687201706.pptx4_5785326174687201706.pptx
4_5785326174687201706.pptx
 
ADRENAL GLAND.pptx
ADRENAL GLAND.pptxADRENAL GLAND.pptx
ADRENAL GLAND.pptx
 
PfC.pptx
PfC.pptxPfC.pptx
PfC.pptx
 
bloodsmear-141130214419-conversion-gate02.pdf
bloodsmear-141130214419-conversion-gate02.pdfbloodsmear-141130214419-conversion-gate02.pdf
bloodsmear-141130214419-conversion-gate02.pdf
 
bloodfilmformalaria-150420154949-conversion-gate01.pdf
bloodfilmformalaria-150420154949-conversion-gate01.pdfbloodfilmformalaria-150420154949-conversion-gate01.pdf
bloodfilmformalaria-150420154949-conversion-gate01.pdf
 
BLOOD FILM COMMENT part one.pptx
BLOOD FILM COMMENT part one.pptxBLOOD FILM COMMENT part one.pptx
BLOOD FILM COMMENT part one.pptx
 

Recently uploaded

Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 

COAGULATION NAPO.pptx

  • 2. INTRODUCTION •Coagulation or clotting means to stop the flow of blood by forming a clot or a process of changing from a liquid to a gel. •It involves; the blood vessels, blood coagulation factors, inhibitors, platelets, fibrinolytic system as well as co-factors to achieve haemostasis. •Coagulation studies are a group of haematologic studies that reflect the function of blood vessels, platelets, and coagulation factors, which all work in harmony to achieve haemostasis. •Clinician must have access to a variety of relevant tests in order to achieve a specific or correct diagnosis. •A blood clot is formed by a network of fibrin threads. In this network, there are trapped red blood cells, platelets and white blood cells. 2
  • 3. DEMONSTRATION OF COAGULATION IN VIVO (INTRO. CONT’D) 3 Factor X- Stuart-Prower Factor IX- Christmas Factor XI- Plasma Thromboplastin Antecedent Factor XII- Hageman
  • 4. CLINICAL SIGNIFICANCE •It is to achieve haemostasis; (Thrombosis and haemorrhage) •Clotting disorders can cause a dangerous amount of bleeding or clotting. Coagulation tests measure various proteins and how they function. •Liver disease, Thrombophilia, Haemophilia interfere with an individual’s ability to clot. •Coagulation tests are useful in monitoring people who take medications that affect clotting ability. Conditions that can cause coagulation problems include: 4
  • 5. PRINCIPLE OF TEST •To evaluate the overall efficiency of the extrinsic pathway (Prothrombin) and intrinsic pathway (Activated prothrombin time test) •When blood vessel walls are damaged, the blood vessels contract to slow down the blood stream. The damaged cells from the vessel’s inner wall (endothelium) trigger several processes, including the activation of platelets and the clotting mechanism. Activated platelets stick together (adhesion) and form complexes (aggregation) that result in the first haemostatic plug in the vessel wall to stop the bleeding. Activated platelets also form the surface for the clotting process. •Clotting (coagulation) occurs through the formation of a network of fibrin, involving the 'clotting factors' being activated. The fibrin network and the haemostatic plug form a secure solution for stopping bleeding and give the body the opportunity to repair the blood vessel. 5
  • 6. PRINCIPLE OF CS-1600 •The CS-1600 is equipped with an optical fibre that supplies light at 4 different wavelengths, and a detector capable of receiving light in multiple wavelengths. •Multi-wavelength detector for transmitted light at 405, 575, 660 and 800 nm by splitting the light from a halogen lamp into beams •It allows measurement of multiple parameters with varying methodologies simultaneously. •Measurement principles (clotting, chromogenic, immunoturbidimetric) are combined in one analyzer. •8 channels for clotting, chromogenic and immunoassays 6
  • 7. PREPARATION BEFORE THE TEST •Ensuring the info on sample corresponds with patient information •The blood obtained should be only from the veins and must be clean and atraumatic. •The sample must be in a sodium citrate anticoagulant tube and should be introduced without frothing. •Preparation of platelet poor plasma (4 degrees Celcius, span at 4000rpm for 13 mins.) •For transportation of sample, sample should be transported with crushed ice and stored at -40 degrees Celsius and thawed when needed. 7
  • 8. REQUIRED SAMPLE AND SAMPLE TUBE Required sample is plasma and should be obtained by centrifuging blood collected by venipuncture into a blue-top tube containing 3.2% buffered sodium citrate. (9:1) 8
  • 9. MATERIALS NEEDED •Water bath •Timer •Marker or pencil •Sodium citrate tubes •Calcium chloride •Tissue thromboplastin •Micropipette and pipette tips •Centrifuge •AUTOMATED ANALYSER (SYSMEX CS-1600) 9
  • 10. METHODOLOGY (Prothrombin) •Set water bath at 37 degree Celsius and place a glass tube in it •Add calcium chloride (CaCl₂) another test tube and allow to warm •Pipette 0.1ml of patient sample into test tube and add 0.1ml of tissue thromboplastin •Allow the mixture to warm for 3minutes. •Wick 0.1ml of pre-warmed CaCl₂ and add to patient sample. •As soon as a clot is seen, the timer is stopped. This time indicates the prothrombin time. •Duplicate the test for inconveniences •Calculate the average time in seconds for patient and control 10
  • 11. RESULTS AND ITS INTERPRETATION •11 to 16 seconds for prothrombin time test •30 to 40 seconds for activated prothrombin time test •INR (International Normalized ratio):The INR is a calculation that adjusts for changes in the PT reagents and allows for results from different laboratories to be compared. •ISI (International Standardized index): The International Normalized Ratio (INR)/International Sensitivity Index (ISI) system was developed as a way to standardize the prothrombin time during the monitoring of patients undergoing oral anti-coagulant therapy with vitamin K antagonists 11
  • 12. SOURCES OF ERRORS •Undetailed medical history e.g. Aplastic anaemia, thrombocytopenia •Drugs that act as inhibitors to coagulation/oral anticoagulants •Diseases; obstructive liver disease and vitamin K deficiency. 12
  • 13. REFERENCES •Haemostasis - Sysmex Europe. Available at: https://www.sysmex- europe.com/products/diagnostics/haemostasis.html (Accessed: November 28, 2022). •Pietrangelo, A. (2018) Coagulation tests: Types, procedure, and results, Healthline. Healthline Media. Available at: https://www.healthline.com/health/coagulation-tests (Accessed: November 28, 2022). •Sysmex. Available at: https://www.sysmex-ap.com/wp-content/uploads/2020/08/Sysmex_CS- 1600Bro2019_FinalLR.pdf (Accessed: November 28, 2022). 13